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extra expenses of multiple seinings and sorting common to most polyculture situations. Any remaining trout not captured during the spring
harvest would not be totally wasted incatfish production ponds.
Rainbow trout can be successfully and economically reared during the winterseason insouthern Arkansas. Profits of$44.00 per 0.9 m1cage
and $780.00 per hectare are obtainable. Producers should stock trout weighing at least 113 g to obtain marketable size fish inone growing season.
Smaller operations should sell their fish onlocal markets to both obtain higher prices and take advantage of the maximum length of the growing
season. Most trout growth is obtained during November and December and again near the latter part of the season during March and Aprilwhen
water temperatures range between 10-16° C.
Table 1. Net production, food conversion efficiency, percent sur-
vival,and average weight gained for rainbow trout reared incages.
™1 19.18 29.45 11.27 1.65 89 122 216 96
2 18.64 29.50 10.86 1.70 87 122 224 102
1 18.45 28.27 9.87 1.89 91 122 207 85
Averages 18.41 29.05 10.64 1.75 89 122 216 95
Table 2. Net production, food conversion efficiency, percent sur-
vival, and average weight gain for rainbow trout production inAr-
kansas ponds.
Stocked Harvested Weight FCE Percent IndividualAverages
Pond weight weight gain survival Stocked Harvested Cain
(kg) (kg) (kg) (g) (g) (g)
1 69 113 44 1.93 100 136 227 91
2 68 130 62 1.37 99 136 264 128
| H.rO |April
Figure 1. Average weekly water temperature ofa 1.6ha pond at 0.5
meter depth insoutheast Arkansas during the winter of 1979-80.
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THE STATE OF CYTIDINE3,5 CYCLIC MONOPHOSPHATE (CYCLIC CMP) RESEARCH
The status ofcyclicCMP is unclear although the presence ofcyclic CMP radioimmunoreactive material (CRIRM) has been demonstrated in
a variety of biological tissues and fluids. Furthermore, marked changes in cyclicCMP and CRIRM have occurred at certain times after partial
hepatectomy during liver regeneration. Inaddition, CRIRM is known to increase in cell free systems thought to synthesize the nucleotide from
Ene triphosphate. Several cyclic CMP phosphodiesterases have been demonstrated. Argument about the occurrence of cyclic CMP hasibecause although CRIRMco-chromatographs withboth unlabeled authentic cyclic CMP and 'H-cyclic CMP on a number of TLC systems,Mhas a different Rf from that of 3H-cyclic CMP or unlabeled cyclic CMP on Dowex-1-formate anion exchange chromatography of acidleextracts ofbiological tissue.
The discovery of cyclicAMP and the development of the second messenger concept constituted a revolution inbiological thinking (Suther-
land, 1972). Incontrast, after almost ten years ofresearch incyclic CMP,it remains uncertain that this nucleotide is a naturally occurring com-
pound or that ithas any biological function at all.For example, in1980 the onlypublications in this area were two abstracts on cyclic CMphospo-
diesterases (PDE) (Conrad and Bloch, 1980; Helfman et al., 1980), and another communication (Murphy and Stone, 1980) onapparent changes in
cyclic CMP concentration during liverregeneration. In1981, only two communications have appeared so far; (Wikberg and Wingren, 1981) one
on non-identity ofCRIRM with authentic cyclic CMP and (Scavennec et al., 1981) the other on the occurrence of cyclic CMP in the urine of
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normal and leukemia patients. Thus, itis possible toreview the salient points of the literature in this area ina veryshort paper and, in so doing,
explain the reasons for the difficulties.
Cyclic CMP was synthesized in1961 by Smith et al., along with the cyclic analogs of the monophosphates of adenosine, guanosine and
uridine. When Steiner and his group (1972) developed radioimmunoassays formost of the cyclic nucleotides, cyclicCMP was omitted. The reason
was that cyclicCMP isinsoluble inpyridine, the solvent used in the succinylation reaction which attaches a succinyl moiety at the 2
' position of
the ribose while succinic anhydride serves as the reagent. The succinyl moiety at position 2 serves several veryimportant functions in the develop-
ment and function ofa radioimmunoassay: 1)Itserves as a point of attachment fora large protein molecule whichmakes the compound anti-
genic when injected, along withFruend's reagent, into the toe pads of rabbits; 2)Itserves as a point of attachment fora methyl tyrosine moiety,
which, in turn, is iodinated with '"I.The succinylation withsuccinic anhydride, surprisingly, could have been carried outinwater. The reactions
are shown inFigure 1. The highlyradioactive '"Imethyl tyrosine ester of 2
'
succinyl cyclicCMP binds to the antibody in the assay and can be dis-
placed by cyclicCMP either as known standards or cyclic CMP present inunknown samples. Figure 2demonstrates a radioimmunoassay control
curve.
Figure 3shows the cross reactivity of the antibody with other cyclic nucleotides, most of which, with the exception of cyclic AMP, present
noproblems. Radioimmunoassays of this type were developed almost simultaneously during 1978-79 (Caillaet al., 1978; Murphy and Stone, 1979)
and again recently (Wikberg and Wingren, 1981). Acommercial assay from Collaborative Research, Walthan, Massachusetts, is also available.
However, it should be emphasized that the founder of this area ofresearch is actually Alexander Bloch of the Roswell Park Memorial Insti-
tute, who, from1970 to the present, has accomplished the followingbasic research:
1) He has demonstrated that cyclicCMP is present inrelatively large amounts (nMoles) inmammalian liver,L1210 cells
and that itincreases inregenerating liver.Bloch characterized cyclic CMPin anumber of ways: Rf values in eight different
thin layer chromatographic (TLC) solvent systems, electrophoretic mobilityinthree different buffers, UVspectra, and mass
spectral analysis (Bloch, 1974a).
2) Hehas demonstrated that the addition of cyclicCMP toL1210 cells, whichhad previously been synchronized by cool-
ing to4°C, produced a burst of mitotic activity.He concluded that the cultures had been synchronized at the Gi phase since
the cells could not likelytraverse the cell cycle in15-30 min. Thus, Bloch was the first to associate cyclicCMP withthe mitotic
phase. He also showed that the addition of cyclic CMP reversed the inhibition of growth produced by cyclic AMP inthe L
1210 cultures (Bloch etal., 1974).
Bloch considered that, despite all these data, definitive proof ofcyclic CMP as a normal physiological cellular component had to await the
demonstration of its enzymatic synthesis inthe cell from which it had been isolated. Bloch did not have a radioimmunoassay available but was
forced to rely on TLCwhichis less accurate quantitatively and much more time consuming. Cyclic CMP has also been found in surprisingly high
concentrations (0.05-2.0 nM) inbacterial culture media from Corynebacterium murisepticus or microbacterium species (Ishiyama, 1975). The
biosynthesis ofa molecule by a cell in which it has been found is important inproving its status as a normal metabolite, because otherwise, one
might conclude that caffeine, nicotine or aspirin are normal human metabolites. These compounds can be isolated from many individuals, are
metabolized by the body and have many pharmacological effects which mighteasily be mistaken forphysiological functions.
Anumber of different phosphodiesterases (PDE's) have been described forcyclic CMP. One, whichhas been purified byConrad and Bloch
(1980), is of relatively highmolecular weight and lowKm and is apparently specific for cyclicCMP only. Another PDE, which has been purified by
Helfman et al., (1980), hydrolizes both cyclic AMP and cyclic CMP at different sites and has a molecular weight of only 33,000. Interestingly
enough, the cyclic CMP PDE's are notinhibited by the methyl xanthines as are the PDE's of the purine cyclic nucleotides.
Cech and Ignarro (1977 and 1978) using alpha"P labeled CTP as substrate witheither Ma++ orFe ++ as cofactors at neutral pH,reported
the biosynthesis of cyclic CMP inboth mouse and rat liver homogenates, both normal and regenerating, as well as in other rodent tissues. The
product was reported as having been characterized with alumina column chromatography, on Dowex-1-formate, PEI cellulose, and recrystalliza-
tion to constant specific activity in two solvents. However, Krishna (1979) showed that the presumed "P cyclic CMP had a different Rf from the
'H cyclic CMP marking pool. We investigated a similar system and found a large number of radioimmunoreactive compounds among the pro-
ducts of the reaction. Thus, this area is in complete disarray at the present time. Recently Wikberg et al., (1981) has demonstrated the problem
quite clearly (Fig.4and 5).
Figure 4 shows work carried outby Wikberg, who has developed a radioimmunoassay quite similar to the others, but which uses 5Hcyclic
CMP as the labelled compound to be displaced from the antibody rather than '"L methyl tyrosine derivatives used in the other systems. This
figure compares to different chromatographs carried out onidentical 0.9 X 15 cm AGl-X-8-formate coumns eluted with 0.2 Nformic acid. One
column, the solid line, was loaded with perchloric acid soluble fraction from 3-5 grams of rat liver,and an identically loaded column was further
charged with 10 pMoles of JHcyclic CMP. The solid line represents radioimmunoreactivity, and the dotted line, radioactivity. Itis evident that
these peaks do not coincide. Figure 5is similar, but the tandem column was loaded with 10 pMoles of unlabeled cyclic CMP. Inthis figure, the
dotted line represents radioimmunoreactivity on the tandem column.
The treatment of CRIRM withpronase, a proteolytic enzyme, increases the radioimmunoreactive cyclic CMP material bya factor of4 but
does notchange itsRf. Itshould be evident that a radioimmunoassay which does notdistinguish between the compound it was designed to quanti-
tate and a different uncharacterized material is of doubtful value.
CRIRM has been noted by others but has been assumed tobe a peptide whichbinds cyclic CMP and which competes with the antibody for
the nucleotide. On the other hand, the material may be a peptide whichis an artifact of extraction with perchloric acid and which has a sequence
ofamino acids identical to some portion of the carrier protein molecule, originallyused tomake the antibody. This is not likelysince a variety of
proteins have been used as carriers among the radioimmunoassays inuse.
Figure 6(Murphy and Stone, 1980) was produced by measuring the changes in cyclicCMP in regenerating liver after partial hepatectomy-
The animals were accompanied by suitable control groups. The perchlorate soluble supernatants were chromatographed upon 3 X 1cm Dowex-
1-formate columns with0.1 formic acid. The samples inthe peak tubes were further characterized byTLCin which the CRIRMmaterial was co-
chromatographed withJH cyclic CMP and unlabeled cyclicCMP.
Itwould be most interesting to ascertain if radioimmunoassayable reactive material similar to that isolated in cyclic radioimmunoassay
would be found forcyclic AMPand cyclic GMP in Wikberg type systems. The close approximation of the Rf of Wikberg's CRIRM peak with
cyclicCMP itself is a technical problem which must be solved before this area can progress.
Itis the opinion of Bloch. and also of the present authors, that cyclicCMP is a rather common cyclic nucleotide, but it is usually bound to
some cellular constituents(s), and it may appear in free form for only relatively short periods during some physiological process in a manner
analogous to norepinephrine or acetycholine.
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General Notes
Figure 2. Standard immunoassay curve forcyclicCMP
Figure 1. Structures of cyclic CMP derivatives synthesized.
Figure 4. Chromatography of cold perchloric acid extracts of rat
liver on large with »H cyclic CMP marking pool added. AG 1-X8
columns. (From Wikberg et al., 1981).
¦>. Chromatography ofcold perchloric acid extracts from ratth unlabelled cyclic CMP added to tandem column. (Fromgetal., 1981). Figure 6. Changes in the cyclic CMP of rat liver following 70%hepatectomy. (From Murphy and Stone, 1980).
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ANOMALIES OF BOBCAT SKULLS (FELIS RUFUS) INARKANSAS
Examination of 275 bobcat skulls (Felis rufus) from Arkansas, preserved in the Collection of Recent Mammals, Arkansas State University
Museum of Zoology (ASUMZ), revealed fiveanomalous forms whichranged from dental irregularity to supernumerary cranial bones.
Sutural anomalies were found inseveral skulls. The normal junction of the coronal (C) and sagittal (S) sutures isillustrated inFigure 1, #
6926. Thisbregmatic junction forms after fontanelle ossification of the frontal and parietal bones. Inthe fetal skull, cartilagenous "soft spots" or
fontanelles exist at the future junctional site, and ifossification among the bones is uneven, waved or otherwise malformed sutures may result.
Twoof the more pronounced sutural anomalies found inArkansas bobcats are illustrated inFigure 1, #'s 7706 and 6765. Bregmatic bone forma-
tion can also cause abnormal junctions ifankylosis obliterates one or more sutures (Pratt, 1942; Manville, 1959). We did notattempt to distinguish
between anomalies caused by these factors.
Bregmatic bones (those formed at the anterior fontanelle) occur commonly inthe beaver (Castor) and porcupine (Erethizori) (Schultz, 1923)
and result from one or more ossification centers developing in the anterior fontanelle, thereby forming additional bones as the parietals and
frontals complete ossification around them. Occurrences of bregmatic bones inbobcats are discussed in the literature (Pratt, 1942; Manville,
1959;Mahan, 1980). Hall and Kelson (1959) (probably unknowingly) depicted a bregmatic bone intheir illustration of a bobcat skull. Bregmatic
fontanelle bones were found in 41 of 275 (14.9%) Arkansas bobcat skulls examined, and varied in size, shape, and number. Representatives of
variations seen in Arkansas skulls are illustrated inFigure 2. The nature of these bones inArkansas bobcats is similar to reports from other areas:
14.7% inNebraska (Mahan, 1980); 16.8% in Oregon, 14.6% inNevada, 15.5% nationally (as represented in the U.S. National Museum) (Man-
ville, 1959). Manville also pointed out deviations from this apparent trend: 37.5% of 32 specimens from West Virginia,44.0% of nine from Mis-
sissippi and 7.0% of 158 from Texas. Pratt (1942) found anomalous bones in17.5% of his museum study material, and Progulske (1952) found 15
of 72 (20.8%) skulls from Virginiaand NorthCarolina tohave anomalous bones. Usually, only a single extra bone occurs; however, inthe Arkan-
sas material examined, one skull (Fig. 2, tt 7471) exhibited two additional bones (0.4% of sample). Similarly,Mahan (1980) found only one such
pair of bones (0.9%) in Nebraska and Pratt (1942) reported two (0.12% ofhis sample). Furthermore, Pratt reported only one incidence involving
three anomalous bones ina sample of 2154 skulls. ASUMZ 7734 (Fig. 2) illustrates an Arkansas specimen exhibiting this trinity of extra bones
(0.4% of sample), representing the second documented record. No correlation was found between sex or geographic location and presence of
anomalous bones in Arkansas bobcats.
Wormian bones are those which are sutural inorigin, as contrasted with bregmatic bones which are fontanellic inorigin.Itis sometimes
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